SLC5A2 and hydrops fetalis: This coupled with tertiary healthcare where almost three-fourths of our patients were on RAS blockers, >90% on statins, and 41.9% on SGLT2-i may account for the low prevalence of HF, LVSD, and asymptomatic high-grade LVDD.